Pyrantel
This medicine should always be taken exactly as described in this package leaflet or as directed by your doctor or pharmacist.
The active substance of the medicine is pyrantel. Owix is an antiparasitic medicine, intended for children aged 6 and over and adults for the treatment of intestinal infection with pinworms - white, thread-like parasites. The medicine works on the muscles of intestinal parasites. The paralyzed parasites are removed from the intestine as a result of intestinal peristalsis. Pyrantel does not irritate the intestines or cause the movement of worms. It acts on mature forms and parasites in the early stages of development, but does not act on larvae during their migration in tissues.
The condition for using the medicine is the confirmation of the presence of pinworms in the stool and/or the anal area. Pinworms are small, white, parasitic worms that live in the intestine. They look like white cotton threads, and the females are about 10 mm long. Single pinworms are difficult to notice, but when they multiply excessively, white, moving worms can be seen in the stool. The presence of pinworms can also be confirmed by examining the anal area of a sleeping child in the evening (best 2 hours after falling asleep, when the process of laying eggs takes place). Pinworms lay a large number of small eggs that are invisible to the naked eye. After ingestion, the eggs travel through the human digestive system, down to the large intestine, and there they transform into mature individuals within 2-6 weeks. Mature females lay eggs in the anal area, causing persistent itching, leading to constant scratching. As a result, the area becomes irritated, and the eggs are transferred to the hands, and then through biting nails or licking fingers to the mouth, i.e., self-infection occurs, or they are transferred to other family members through direct or indirect contact, e.g., towels, bedding, toys, furniture. Symptoms of pinworm infection are mainly observed in children. However, the disease occurs at any age, although children are often the main carriers (infection with parasites can occur, for example, in nurseries, kindergartens, sandboxes). If a child has pinworms, it is very easy for other family members to become infected. Pinworm infection manifests as a strong feeling of itching in the anal area (not present in all infected individuals), usually at night, which often causes inflammatory conditions. In children infected with pinworms, irritability, nervousness, insomnia, bedwetting, or abdominal pain and loss of appetite may occur. In girls, it can lead to vulvitis and vaginitis, which manifests as itching, burning, and white discharge. In such cases, you should contact your doctor. It is very important to maintain proper hygiene, especially personal hygiene, to prevent self-infection or transmission of the infection to other people. The following rules should be applied for at least 6 weeks after the end of treatment. Prevention of pinworm infection is primarily:
It is important that in the case of parasite infection, the entire family of the patient should follow enhanced personal hygiene. Considering the frequent collective occurrence of pinworm infection, treatment should be carried out simultaneously in all people living together, and it should be repeated. In case of suspected re-infection, you should contact your doctor.
Before starting treatment with Owix, you should discuss it with your doctor
If the above warnings apply to you currently or are related to situations that have occurred in the past, you should contact your doctor.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or plan to take.
Take the medicine during or after a meal.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, consult your doctor or pharmacist before taking this medicine.
Pregnancy
It is not recommended to take Owix during pregnancy. If treatment is necessary, you should contact your doctor.
Breastfeeding
It is not recommended to take Owix while breastfeeding. If treatment with the medicine is necessary, you should stop breastfeeding.
Fertility
There is no available data on the effect of the medicine on fertility.
There is no available data on the effect of Owix on driving and using machines.
This medicine should always be taken exactly as described in the package leaflet or as directed by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist.
Dosage
The dose should be repeated after 2 or 3 weeks from the first dose. Do not exceed the recommended dose of the medicine.
After 14 days from the end of treatment, control parasitological tests should be performed.
Due to the pharmaceutical form of Owix, 250 mg, tablets, it is not intended for use in children under 6 years of age.
There is a medicine containing pyrantel in the form of an oral suspension available on the market, intended for use in small children as well.
The following table shows the dosage of Owix tablets depending on the patient's body weight.
Body weight | Single dose | Single dose [mg] |
17-28 kg | 1 tablet | 250 mg |
29-39 kg | 1½ tablets | 375 mg |
40-50 kg | 2 tablets | 500 mg |
51-62 kg | 2½ tablets | 625 mg |
63-75 kg | 3 tablets | 750 mg |
Adults with body weight >75 kg | 4 tablets | 1,000 mg |
Patients with liver function disorders
Patients with liver function disorders should contact their doctor before taking the medicine. The doctor may recommend a lower dose, as the medicine may have an adverse effect on the liver.
Method of administration
Take the medicine orally during or after a meal, with water. Before swallowing, the tablet should be thoroughly chewed or crushed.
In case of taking a higher dose of the medicine than recommended, you should immediately contact your doctor or pharmacist.
After overdose, the following symptoms may occur: vision disturbances, disorientation, dizziness, fainting, or a feeling of dizziness when getting up from a lying or sitting position, sweating, unprecedented feeling of fatigue or weakness, irregular heartbeat; cramps, tremors, and muscle weakness; feeling of exhaustion, breathing difficulties, loss of consciousness.
In case of any further doubts related to the use of this medicine, you should contact your doctor or pharmacist.
Like all medicines, Owix can cause side effects, although not everybody gets them.
After taking the medicine, side effects do not occur frequently and disappear after stopping treatment.
If you experience any side effects, including any not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help gather more information on the safety of the medicine.
Keep the medicine out of the sight and reach of children.
Store in a temperature below 25°C. Store in the original packaging.
Do not use this medicine after the expiry date stated on the carton. The expiry date stated on the carton is the last day of the stated month.
The inscription on the packaging after the abbreviation EXP means the expiry date, and after the abbreviation Lot means the batch number.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Owix tablets are round, flat on both sides, with a dividing line; yellowish-gray with a slight greenish tint, with faint speckles on the surface, with an orange scent. The tablet can be divided into equal doses.
The pack contains 3 tablets.
Zakłady Farmaceutyczne POLPHARMA S.A.
ul. Pelplińska 19, 83-200 Starogard Gdański
phone: +48 22 364 61 01
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.